Gemmer Asset Management LLC Bio N Tech Se Transaction History

Gemmer Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$216.64 - $362.52 $2,383 - $3,987	-11 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$205.93 - $447.23 $1,647 - $3,577	-8 Reduced 42.11%	11 $3,000
Q2 2021 Jul 23, 2021	SELL	$113.32 - $241.49 $2,039 - $4,346	-18 Reduced 48.65%	19 $4,000
Q4 2020 Jan 28, 2021	SELL	$72.71 - $129.54 $2,181 - $3,886	-30 Reduced 44.78%	37 $3,000
Q3 2020 Oct 21, 2020	BUY	$57.81 - $104.17 $115 - $208	2 Added 3.08%	67 $5,000
Q2 2020 Jul 31, 2020	BUY	$38.58 - $66.74 $2,507 - $4,338	65 New	65 $4,000

324

39.1M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.9B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.